These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19593171)

  • 41. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient.
    Krystal AD; Watts BV; Weiner RD; Moore S; Steffens DC; Lindahl V
    J ECT; 1998 Mar; 14(1):5-14. PubMed ID: 9661088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of gabapentin and ketamine in acute and chronic pain after hysterectomy.
    Sen H; Sizlan A; Yanarates O; Emirkadi H; Ozkan S; Dagli G; Turan A
    Anesth Analg; 2009 Nov; 109(5):1645-50. PubMed ID: 19843803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
    Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
    Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.
    Mason BJ; Light JM; Williams LD; Drobes DJ
    Addict Biol; 2009 Jan; 14(1):73-83. PubMed ID: 18855801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
    Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
    Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gabapentin withdrawal syndrome in the presence of a taper.
    Tran KT; Hranicky D; Lark T; Jacob Nj
    Bipolar Disord; 2005 Jun; 7(3):302-4. PubMed ID: 15898970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gabapentin's acute effect on mood profile -- a controlled study on patients with alcohol withdrawal.
    Bonnet U; Specka M; Leweke FM; Nyhuis P; Banger M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):434-8. PubMed ID: 17178181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of alcohol withdrawal syndrome with gabapentin.
    Bonnet U; Banger M; Leweke FM; Maschke M; Kowalski T; Gastpar M
    Pharmacopsychiatry; 1999 May; 32(3):107-9. PubMed ID: 10463378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gabapentin for the treatment of alcohol use disorder.
    Mason BJ; Quello S; Shadan F
    Expert Opin Investig Drugs; 2018 Jan; 27(1):113-124. PubMed ID: 29241365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flumazenil in alcohol withdrawal.
    Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
    Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.
    Mariani JJ; Rosenthal RN; Tross S; Singh P; Anand OP
    Am J Addict; 2006; 15(1):76-84. PubMed ID: 16449096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam.
    Krupitsky EM; Rudenko AA; Burakov AM; Slavina TY; Grinenko AA; Pittman B; Gueorguieva R; Petrakis IL; Zvartau EE; Krystal JH
    Alcohol Clin Exp Res; 2007 Apr; 31(4):604-11. PubMed ID: 17374039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy.
    Ko SH; Kwon HS; Yu JM; Baik SH; Park IB; Lee JH; Ko KS; Noh JH; Kim DS; Kim CH; Mok JO; Park TS; Son HS; Cha BY
    Diabet Med; 2010 Sep; 27(9):1033-40. PubMed ID: 20722677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
    Anton RF; Youngblood M
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1878-83. PubMed ID: 17067352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral gabapentin for photorefractive keratectomy pain.
    Kuhnle MD; Ryan DS; Coe CD; Eaddy J; Kuzmowych C; Edwards J; Howard RS; Bower KS
    J Cataract Refract Surg; 2011 Feb; 37(2):364-9. PubMed ID: 21241922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.